Literature DB >> 27511381

Effects of High-cholesterol Diet on Pravastatin Disposition in the Perfused Rat Liver.

Atsushi Kawase1, Ayumi Handa2, Masahiro Iwaki2.   

Abstract

BACKGROUND AND OBJECTIVES: Various nutrients modulate the expression of transporters; however, the effect of a high-cholesterol (HC) diet on the expression and function of hepatic transporters remains unclear. Here, we examined the effects of an HC diet on drug disposition via hepatic transporters, including organic anion-transporting polypeptide (Oatp), multidrug resistance-associated protein (Mrp), and bile salt export pump (Bsep).
METHODS: In situ perfused rat liver system was performed. The levels of pravastatin, which is taken up into hepatocytes by Oatp and excreted into bile by Mrp2, in the perfusate and in bile were measured using high-performance liquid chromatography.
RESULTS: Pravastatin was rapidly eliminated in control and HC rats; however, the cumulative amounts of excreted in bile were significantly higher in HC rats than in controls possibly because of the enhanced bile flow in HC rats (0.93 ± 0.05 μL/min in control, and 1.22 ± 0.18 μL/min in HC). Real-time reverse-transcriptase polymerase chain reaction (PCR) and western blot assessment of the mRNA and protein levels of hepatic transporters showed a significant downregulation of the Oatp1a1 and Bsep proteins in HC rats, whereas no differences in Mrp2 and Mrp3 levels were observed between HC and control rats. The analysis of the localization of Mrp2 on the canalicular membrane by immunofluorescence showed no changes in HC rats, although Mrp2 was readily internalized from the canalicular membrane under specific conditions.
CONCLUSIONS: The findings of the present study indicate that the HC diet affected the biliary excretion of pravastatin concomitant with increased bile flow, despite minimal effects on the expression of hepatic transporters. The HC diet could promote the biliary excretion of other drugs and metabolites that are substrates of Mrp2 and Bsep.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27511381     DOI: 10.1007/s13318-016-0367-9

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  36 in total

1.  Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes.

Authors:  D Nakai; R Nakagomi; Y Furuta; T Tokui; T Abe; T Ikeda; K Nishimura
Journal:  J Pharmacol Exp Ther       Date:  2001-06       Impact factor: 4.030

2.  The effect of choleretic and of hydrocholeretic agents on bile flow and bile solids in the isolated perfused liver.

Authors:  R W BRAUER; R L PESSOTTI
Journal:  Science       Date:  1952-02-08       Impact factor: 47.728

3.  Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats.

Authors:  M Yamazaki; K Kobayashi; Y Sugiyama
Journal:  Biopharm Drug Dispos       Date:  1996-10       Impact factor: 1.627

4.  Characterization of inducible nature of MRP3 in rat liver.

Authors:  K Ogawa; H Suzuki; T Hirohashi; T Ishikawa; P J Meier; K Hirose; T Akizawa; M Yoshioka; Y Sugiyama
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-03       Impact factor: 4.052

5.  Ethacrynic-acid-induced glutathione depletion and oxidative stress in normal and Mrp2-deficient rat liver.

Authors:  Bin Ji; Kousei Ito; Shuichi Sekine; Ai Tajima; Toshiharu Horie
Journal:  Free Radic Biol Med       Date:  2004-12-01       Impact factor: 7.376

6.  Cholesterol is essential for mitosis progression and its deficiency induces polyploid cell formation.

Authors:  Carlos Fernández; María del Val T Lobo Md; Diego Gómez-Coronado; Miguel A Lasunción
Journal:  Exp Cell Res       Date:  2004-10-15       Impact factor: 3.905

7.  Increased effects of ginsenosides on the expression of cholesterol 7α-hydroxylase but not the bile salt export pump are involved in cholesterol metabolism.

Authors:  Atsushi Kawase; Ayano Yamada; Yuko Gamou; Chika Tahara; Fumiaki Takeshita; Kazuya Murata; Hideaki Matsuda; Keiichi Samukawa; Masahiro Iwaki
Journal:  J Nat Med       Date:  2012-10-30       Impact factor: 2.343

8.  Differential effect of taurocholic acid on hepatic arterial resistance vessels and bile flow.

Authors:  W W Lautt; T R Daniels
Journal:  Am J Physiol       Date:  1983-04

9.  Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans.

Authors:  Takao Watanabe; Hiroyuki Kusuhara; Kazuya Maeda; Yoshihisa Shitara; Yuichi Sugiyama
Journal:  J Pharmacol Exp Ther       Date:  2008-11-10       Impact factor: 4.030

10.  Effect of diet on expression of genes involved in lipid metabolism, oxidative stress, and inflammation in mouse liver-insights into mechanisms of hepatic steatosis.

Authors:  Helen J Renaud; Julia Y Cui; Hong Lu; Curtis D Klaassen
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.